Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis

Acta Neurologica Scandinavica

Volumn 128, Issue 4, 2013, Pages 257-264

  Oketa, Y ^a   Higashida, K ^a   Fukasawa, H ^a   Tsukie, T ^a   Ono, S ^a  

^a TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Epidermis; Fused in sarcoma; Immunohistochemistry; Skin

Indexed keywords

FUSED IN SARCOMA PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EPIDERMIS; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; OPTICAL DENSITY; PROTEIN EXPRESSION; SKIN;

AMYOTROPHIC LATERAL SCLEROSIS; EPIDERMIS; FUSED IN SARCOMA; IMMUNOHISTOCHEMISTRY; SKIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RNA-BINDING PROTEIN FUS; SKIN;

EID: 84883748422     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12114     Document Type: Article

References (29)

1. Ono S, Toyokura Y, Mannen T, Ishibashi Y. Amyotrophic lateral sclerosis: histological, histochemical, and ultrastructural abnormalities of skin. Neurology 1986;36:948-56.
2. Ono S, Yamauchi M. Elastin cross-linking in the skin from patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1994;57:94-6.
3. Ono S, Imai T, Aso A, Yamano T, Shimizu N. Alterations of skin glycosaminoglycans in patients with ALS. Neurology 1998;51:399-404.
4. Furukawa T, Toyokura Y. Amyotrophic lateral sclerosis and bedsores. Lancet 1976;1:862.
5. Aman P, Panagopoulos I, Lassen C et al. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996;37:1-8.
6. Yamashita S, Mori A, Sakaguchi H et al. Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation. J Neurol 2012;259:1039-44.
7. Vance C, Rogelj B, Hortobágyi T et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009;323:1208-11.
8. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009;323:1205-8.
9. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(Suppl):96-107.
10. Folstein MF, Folsttein SE, Mchugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-98.
11. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-63.
12. Pessolano FA, Súarez AA, Monteiro SG et al. Nutritional assessment of patients with neuromuscular diseases. Am J Phys Med Rehabil 2003;82:182-5.
13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61-5.
14. de Morton NA, Keating JL, Davidson M. Rasch analysis of the Barthel Index in the assessment of hospitalized older patients after admission for an acute medical condition. Arch Phys Med Rehabil 2008;89:641-7.
15. Cedarbaum JM, Stambler N, Malta E et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
16. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
17. Ono S, Hu J, Imai T, Shimizu N, Tsumura M, Nakagawa H. Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:199-203.
18. Suzuki M, Mikami H, Watanabe T et al. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 2010;122:367-72.
19. Ono S, Imai T, Shimizu N, Nakagawa H, Hu J. Ciliary neurotropic factor in skin biopsies of patients with amyotrophic lateral sclerosis. Lancet 1998;352:958-9.
20. Suzuki M, Watanabe T, Mikami H et al. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis. J Neurol Sci 2009;285:125-9.
21. Watanabe T, Oketa Y, Yamano T, Ono S. An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2010;298:52-6.
22. Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell 2009;136:1001-4.
23. Andersson MK, Stahlberg A, Arvidsson Y et al. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 2008;9:37.
24. Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010;19:R46-64.
25. Neumann M, Sampathu DM, Kwong LK et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-3.
26. Lai SL, Abramzon Y, Schymick JC et al. FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2011;32:550.e1-4.
27. Chiò A, Calvo A, Moglia C et al. A de novo missense mutation of the FUS gene in a "true" sporadic ALS case. Neurobiol Aging 2011;32:553.e23-6.
28. Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995;38:691-5.
29. Mackenzie IR, Bigio EH, Ince PG et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 2007;61:427-34.